Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Other
Commiphora Myrrha Whole is a botanical oleo-gum resin primarily utilized in homeopathic preparations and topical oral health products for its purported anti-inflammatory and antimicrobial properties.
Name
Commiphora Myrrha Whole
Raw Name
COMMIPHORA MYRRHA WHOLE
Category
Other
Drug Count
8
Variant Count
8
Last Verified
February 17, 2026
About Commiphora Myrrha Whole
Commiphora Myrrha Whole is a botanical oleo-gum resin primarily utilized in homeopathic preparations and topical oral health products for its purported anti-inflammatory and antimicrobial properties.
Detailed information about Commiphora Myrrha Whole
References used for this content
This page is for informational purposes only and does not replace medical advice. Consult a qualified healthcare professional before using any medication containing Commiphora Myrrha Whole.
Commiphora Myrrha Whole refers to the complete oleo-gum resin obtained from the stems of the Commiphora myrrha tree, a member of the Burseraceae family native to the Arabian Peninsula and Northeast Africa. In clinical and pharmacological contexts, this substance is categorized as a botanical drug or a homeopathic active ingredient, depending on its concentration and preparation method. It has been recognized for centuries in traditional medicine systems, but modern clinical pharmacology has begun to isolate its specific bioactive constituents to understand its therapeutic potential. Commiphora Myrrha Whole belongs to a class of substances often referred to as botanical analgesics and anti-inflammatories. It is frequently included in the Homeopathic Pharmacopoeia of the United States (HPUS) for conditions involving mucous membrane inflammation.
Historically, the FDA has classified myrrh as 'Generally Recognized as Safe' (GRAS) when used as a flavoring agent or food additive. However, when marketed for specific therapeutic claims—such as treating gingivitis, pharyngitis, or skin wounds—it is regulated under the OTC (Over-the-Counter) monograph system or as a homeopathic drug. It is important to note that while Commiphora Myrrha Whole has a long history of use, patients should consult with a healthcare provider to ensure its use is appropriate for their specific medical history. The 'whole' designation implies that the resin contains its full spectrum of volatile oils (terpenes), gums (polysaccharides), and resins (triterpenoids).
The pharmacological activity of Commiphora Myrrha Whole is multifaceted, involving several molecular pathways. The primary bioactive components are furanosesquiterpenes, such as curzerene, furanoeudesma-1,3-diene, and lindestrene. These compounds have been shown in laboratory settings to interact with the opioid receptors in the central nervous system, specifically the mu-opioid receptors, which may explain the analgesic (pain-relieving) properties of the resin. Furthermore, Commiphora Myrrha Whole exhibits significant anti-inflammatory activity by inhibiting the production of pro-inflammatory cytokines, including Interleukin-1 beta (IL-1β), Interleukin-6 (IL-6), and Tumor Necrosis Factor-alpha (TNF-α).
At the cellular level, the resin appears to modulate the NF-κB (nuclear factor kappa-light-chain-enhancer of activated B cells) signaling pathway. By inhibiting this pathway, myrrh reduces the expression of enzymes like cyclooxygenase (COX), which are responsible for the synthesis of prostaglandins that mediate pain and swelling. Additionally, the antimicrobial properties of Commiphora Myrrha Whole are attributed to its ability to disrupt the cell membranes of various bacteria and fungi, making it a common ingredient in topical antiseptic and oral hygiene formulations. Your healthcare provider can explain how these mechanisms specifically apply to the condition being treated.
Understanding the pharmacokinetics of a complex botanical like Commiphora Myrrha Whole is challenging because it contains hundreds of individual compounds. However, research into its primary sesquiterpenes provides a baseline for its behavior in the human body.
Commiphora Myrrha Whole is utilized in several therapeutic areas, primarily in OTC and homeopathic contexts. Common uses include:
Commiphora Myrrha Whole is available in several formulations to accommodate different routes of administration:
> Important: Only your healthcare provider can determine if Commiphora Myrrha Whole is right for your specific condition. The safety and efficacy of botanical products can vary significantly between manufacturers.
Dosage for Commiphora Myrrha Whole varies significantly based on the formulation and the condition being addressed. Because this is a botanical substance, there is no single 'standard' dose, but the following ranges are commonly cited in clinical literature and pharmacopoeias:
The safety and efficacy of Commiphora Myrrha Whole have not been established in children under the age of 12. Healthcare providers generally advise against the use of systemic myrrh in pediatric populations unless specifically formulated and supervised by a qualified medical professional. For topical use (such as in a mouthwash), children should be supervised to ensure they do not swallow the solution.
Specific dosage adjustments for patients with kidney disease have not been clinically defined. However, because the metabolites of Commiphora Myrrha Whole are excreted renally, patients with a reduced Glomerular Filtration Rate (GFR) should use the lowest effective dose and monitor for signs of accumulation or toxicity. Talk to your doctor if you have a history of kidney disease.
Since the liver metabolizes the volatile oils and resins in myrrh, patients with hepatic impairment (e.g., cirrhosis, hepatitis) should exercise extreme caution. There is a potential for increased systemic exposure and liver strain. Healthcare providers may recommend avoiding systemic use in cases of severe liver dysfunction.
Geriatric patients often have reduced organ function and may be taking multiple medications (polypharmacy). Dosing should generally start at the lower end of the adult range. Monitoring for gastrointestinal distress and potential drug interactions is critical in this population.
If you miss a dose of Commiphora Myrrha Whole, take it as soon as you remember. If it is almost time for your next scheduled dose, skip the missed dose and resume your regular schedule. Do not double the dose to catch up, as this increases the risk of side effects like diarrhea or abdominal pain.
Signs of an overdose of Commiphora Myrrha Whole may include severe diarrhea, abdominal cramping, nausea, vomiting, and a rapid heart rate (tachycardia). In extreme cases of systemic ingestion of concentrated essential oil, central nervous system depression or kidney irritation may occur. If an overdose is suspected, contact your local poison control center or seek emergency medical attention immediately.
> Important: Follow your healthcare provider's dosing instructions. Do not adjust your dose or the frequency of use without medical guidance. Natural products are not inherently safe and must be used with the same caution as synthetic medications.
When used as directed, Commiphora Myrrha Whole is generally well-tolerated, but some individuals may experience mild adverse effects. The most common side effects include:
> Warning: Stop taking Commiphora Myrrha Whole and call your doctor immediately if you experience any of these serious symptoms.
The long-term safety of Commiphora Myrrha Whole has not been extensively studied in large-scale clinical trials. Potential concerns with chronic use include the development of sensitization (increased allergic reactivity) and possible cumulative effects on the liver or kidneys. It is generally recommended to use myrrh for short durations (e.g., 1-2 weeks for acute conditions) rather than as a long-term daily supplement unless directed by a healthcare provider.
Currently, there are no FDA black box warnings for Commiphora Myrrha Whole. However, this does not mean the substance is without risk. The lack of a black box warning is often due to the fact that many botanical products have not undergone the same rigorous, multi-phase FDA clinical trial process required for synthetic prescription drugs. Patients should treat this substance with the same level of caution as any medication with a formal warning.
Report any unusual symptoms or persistent side effects to your healthcare provider. Your feedback is essential for monitoring the safety of botanical and homeopathic products.
Commiphora Myrrha Whole is a potent pharmacological agent and should not be treated as a simple 'herbal tea' or harmless supplement. It contains bioactive sesquiterpenes that can affect multiple organ systems. Patients with a history of heart disease, diabetes, or bleeding disorders must consult a physician before use. Furthermore, the quality and purity of myrrh products can vary; ensure you are using a product from a reputable source that follows Good Manufacturing Practices (GMP).
No FDA black box warnings for Commiphora Myrrha Whole. As a botanical resin, it is primarily regulated as a dietary supplement or homeopathic ingredient, which subjects it to different labeling requirements than prescription pharmaceuticals.
If your healthcare provider recommends the use of Commiphora Myrrha Whole for an extended period, the following monitoring may be necessary:
There is no evidence to suggest that Commiphora Myrrha Whole significantly impairs the ability to drive or operate heavy machinery. However, if you experience dizziness or headaches as a side effect, you should avoid these activities until you know how the substance affects you.
Alcohol should be consumed with caution while using systemic Commiphora Myrrha Whole. Alcohol can exacerbate gastrointestinal irritation and may increase the sedative effects of the resin if it interacts with the central nervous system. Additionally, many myrrh tinctures are alcohol-based, which contributes to total alcohol intake.
While Commiphora Myrrha Whole is not known to cause physical dependence or a traditional withdrawal syndrome, stopping it suddenly after long-term use may result in a return of the inflammatory symptoms it was treating. It is always best to taper off any supplement under the guidance of a healthcare professional.
> Important: Discuss all your medical conditions, including any history of allergies or chronic diseases, with your healthcare provider before starting Commiphora Myrrha Whole.
While there are few absolute contraindications for Commiphora Myrrha Whole, it should never be combined with:
For each major interaction, the mechanism typically involves either competitive inhibition of liver enzymes or additive pharmacodynamic effects on the blood or endocrine system. The clinical consequence is usually an increased risk of toxicity from the primary medication or a dangerous shift in physiological markers (like blood sugar). The management strategy is always to consult a doctor before co-administration.
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking, including those used topically.
Commiphora Myrrha Whole must NEVER be used in the following circumstances:
Conditions requiring a careful risk-benefit analysis by a healthcare provider include:
Patients who are allergic to 'Balsam of Peru' often show cross-sensitivity to Commiphora Myrrha Whole. If you have had a reaction to perfumes, flavorings, or other resins, you should be tested for a myrrh allergy before use. Cross-reactivity with other members of the Commiphora genus (like Guggul) is also highly likely.
> Important: Your healthcare provider will evaluate your complete medical history, including any silent conditions, before prescribing or recommending Commiphora Myrrha Whole.
Commiphora Myrrha Whole is classified as unsafe for use during pregnancy (Category X in some traditional herbal classification systems, though not officially categorized by the FDA). Clinical data and historical usage indicate that myrrh can stimulate uterine blood flow and contractions. There is no 'safe' trimester for its use. Its use in fertility treatments is also discouraged as it may interfere with the uterine environment necessary for implantation.
It is unknown whether the bioactive components of Commiphora Myrrha Whole pass into breast milk. However, due to the potential for the volatile oils to cause gastrointestinal distress or allergic reactions in a nursing infant, the use of systemic myrrh is generally discouraged during breastfeeding. Topical use on the breast area is strictly prohibited to prevent infant ingestion.
As previously noted, Commiphora Myrrha Whole is not approved for systemic use in children. The risk of Reye-like symptoms (though not specifically linked to myrrh) and the sensitivity of the pediatric developing liver and kidneys make it a high-risk substance for this population. Topical oral use should only occur under the direct supervision of a pediatric dentist or physician.
In older adults, the primary concerns are decreased renal clearance and the high likelihood of drug interactions. Geriatric patients are more prone to the hypotensive (blood pressure lowering) effects of myrrh. Falls are a significant risk if dizziness occurs. Healthcare providers should perform a thorough medication reconciliation before recommending myrrh to an elderly patient.
Patients with a GFR below 60 mL/min/1.73m² should use Commiphora Myrrha Whole with extreme caution. There is no data on its clearance during hemodialysis or peritoneal dialysis; therefore, it should be avoided in patients with end-stage renal disease (ESRD).
For patients with a Child-Pugh score of B or C, Commiphora Myrrha Whole is generally not recommended. The inability of the liver to process the complex resins can lead to increased systemic toxicity and potential hepatotoxicity.
> Important: Special populations require individualized medical assessment. Never assume a natural product is safe for sensitive groups.
Commiphora Myrrha Whole acts through a complex interplay of its constituent parts. The furanosesquiterpenes (specifically furanoeudesma-1,3-diene and curzerene) act as agonists at the mu-opioid receptors in the brain, providing a central analgesic effect. Simultaneously, the triterpenoids in the resin inhibit the 5-lipoxygenase (5-LOX) and cyclooxygenase (COX) enzymes, which are key players in the inflammatory cascade. This dual action—targeting both the perception of pain and the underlying inflammatory process—makes it unique among botanical medicines.
The dose-response relationship for myrrh is non-linear, meaning that doubling the dose does not necessarily double the effect but may significantly increase the risk of toxicity. The onset of action for topical oral use is relatively quick (15-30 minutes for pain relief), while systemic anti-inflammatory effects may take several days of consistent dosing to become apparent. Tolerance to the analgesic effects has not been formally documented but is a theoretical possibility given its interaction with opioid receptors.
| Parameter | Value |
|---|---|
| Bioavailability | Estimated 15-25% (Oral) |
| Protein Binding | High (>85% suspected) |
| Half-life | 2-4 hours (Primary sesquiterpenes) |
| Tmax | 1-2 hours |
| Metabolism | Hepatic (CYP3A4, CYP2D6) |
| Excretion | Renal (60%), Fecal (40%) |
Commiphora Myrrha Whole consists of 25-40% resin, 30-60% gum, and 3-10% volatile oil. The molecular formula for its primary active sesquiterpene, Curzerene, is C15H20O, with a molecular weight of 216.32 g/mol. The resin is poorly soluble in water but highly soluble in alcohol (ethanol) and oils, which dictates how it is formulated for clinical use.
Commiphora Myrrha Whole is classified as a botanical oleo-gum resin. Within the therapeutic hierarchy, it is considered an herbal analgesic, antiseptic, and anti-inflammatory. It shares some pharmacological similarities with Boswellia serrata (Frankincense) and Curcuma longa (Turmeric).
Common questions about Commiphora Myrrha Whole
Commiphora Myrrha Whole is primarily used for its anti-inflammatory, analgesic, and antimicrobial properties. In modern clinical settings, it is most commonly found in oral care products to treat conditions like gingivitis, mouth sores, and throat irritation. It is also used topically as an antiseptic for minor wounds and skin abrasions. Some traditional and homeopathic practices use it systemically for respiratory or digestive support. However, it should only be used for these purposes under the guidance of a healthcare professional.
The most frequently reported side effects include gastrointestinal issues such as mild nausea, stomach upset, and diarrhea, particularly when taken in systemic forms like capsules. When used as a mouthwash or topical treatment, some individuals may experience local irritation, a burning sensation, or contact dermatitis (a skin rash). These effects are generally mild and resolve once the use of the product is stopped. If you experience severe abdominal pain or a widespread rash, you should contact your doctor immediately. Always start with a small dose to assess your individual tolerance.
Combining alcohol with Commiphora Myrrha Whole is generally discouraged. Alcohol can increase the likelihood of stomach irritation and may enhance any sedative or dizzying effects the resin might have. Furthermore, many myrrh tinctures are already high in alcohol content, so adding more can lead to excessive intake. For the safest results, avoid alcoholic beverages while using systemic myrrh supplements. If you are using a myrrh-based mouthwash, ensure you do not swallow the solution to minimize alcohol exposure.
No, Commiphora Myrrha Whole is considered unsafe during pregnancy and is strictly contraindicated. It has emmenagogue effects, meaning it can stimulate blood flow to the pelvic area and induce uterine contractions. This poses a significant risk of miscarriage or premature labor at any stage of pregnancy. Women who are pregnant or planning to become pregnant should avoid all forms of myrrh, including essential oils and topical salves. Always consult your obstetrician before using any herbal or botanical product during pregnancy.
The time it takes for Commiphora Myrrha Whole to work depends on the condition being treated and the form used. For topical oral issues like canker sores or sore throats, many patients feel temporary relief within 15 to 30 minutes due to its local anesthetic and astringent properties. For systemic anti-inflammatory effects, such as reducing joint pain or swelling, it may take 3 to 7 days of consistent use to notice a difference. If your symptoms do not improve within a week, you should consult a healthcare provider. Do not exceed the recommended duration of use.
Yes, you can typically stop taking Commiphora Myrrha Whole suddenly, as it is not known to cause physical dependence or withdrawal symptoms. However, if you were using it to manage a chronic inflammatory condition, your symptoms may return shortly after discontinuation. It is always a good practice to discuss stopping any supplement with your healthcare provider, especially if it was part of a broader treatment plan. They can help you determine if a different therapy is needed to manage your symptoms. Sudden discontinuation is safe but may lead to a relapse of the original issue.
If you miss a dose of Commiphora Myrrha Whole, take the missed dose as soon as you remember. However, if it is almost time for your next scheduled dose, it is better to skip the missed dose entirely and continue with your regular schedule. Never take two doses at once to make up for a missed one, as this can increase the risk of gastrointestinal side effects like diarrhea. Consistency is key for the effectiveness of botanical supplements, so try to take your doses at the same time each day. Setting a reminder on your phone can help you stay on track.
There is currently no clinical evidence to suggest that Commiphora Myrrha Whole causes weight gain. Unlike some synthetic anti-inflammatory medications like corticosteroids, myrrh does not affect metabolic rate or water retention in a way that leads to increased body weight. In fact, some preliminary animal studies have looked at its potential to help regulate lipid levels, though this is not a confirmed effect in humans. If you experience sudden weight gain or swelling while taking this supplement, it is likely due to another cause and should be evaluated by a doctor. Always monitor your body's response to new supplements.
Commiphora Myrrha Whole can interact with several types of medications, so caution is required. It most notably interacts with blood thinners like warfarin, potentially making them less effective, and with diabetes medications, where it can cause blood sugar to drop too low. It may also interfere with the way your liver processes other drugs through the CYP450 enzyme system. Because of these risks, you must provide your doctor or pharmacist with a full list of all medications and supplements you are currently taking. They can help you determine if there are any dangerous interactions to watch out for.
Commiphora Myrrha Whole is a natural botanical substance, so it does not have a 'generic' version in the way that prescription drugs like lisinopril do. Instead, it is sold by many different manufacturers under various brand names as a dietary supplement, homeopathic remedy, or essential oil. The quality, concentration, and purity can vary significantly between these products. When shopping, look for products that are standardized to contain a specific percentage of active sesquiterpenes and are produced by companies following GMP (Good Manufacturing Practices). Your healthcare provider can recommend a high-quality brand.